Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 5552: BT7480, a novel fully synthetic tumor-targeted immune cell agonist (TICATM) induces tumor localized 4-1BB agonism

Cancer Res (2020) 80 (16_Supplement): 5552.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Christina Claus
  • Claudia Ferrara-Koller
  • Christian Klein
mAbs (2023) 15 (1)
  • Jeffrey L. Wong
  • Jonathan E. Rosenberg
Expert Opinion on Biological Therapy (2021) 21 (7): 863.
Close Modal

or Create an Account

Close Modal
Close Modal